Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.
- 1 December 1993
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 92 (6), 2569-2576
- https://doi.org/10.1172/jci116871
Abstract
TGF-beta effects on angiogenesis, stroma formation, and immune function suggest its possible involvement in tumor progression. This hypothesis was tested using the 2G7 IgG2b, which neutralizes TGF-beta 1, -beta 2, and -beta 3, and the MDA-231 human breast cancer cell line. Inoculation of these cells in athymic mice decreases mouse spleen natural killer (NK) cell activity. Intraperitoneal injections of 2G7 starting 1 d after intraperitoneal inoculation of tumor cells suppressed intraabdominal tumor and lung metastases, whereas the nonneutralizing anti-TGF-beta 12H5 IgG2a had no effect. 2G7 transiently inhibited growth of established MDA-231 subcutaneous tumors. Histologically, both 2G7-treated and control tumors were identical. Intraperitoneal administration of 2G7 resulted in a marked increase in mouse spleen NK cell activity. 2G7 did not inhibit MDA-231 primary tumor or metastases formation, nor did it stimulate NK cell-mediated cytotoxicity in beige NK-deficient nude mice. Finally, serum-free conditioned medium from MDA-231 cells inhibited the NK cell activity of human blood lymphocytes. This inhibition was blocked by the neutralizing anti-TGF-beta 2G7 antibody but not by a nonspecific IgG2. These data support a possible role for tumor cell TGF-beta in the progression of mammary carcinomas by suppressing host immune surveillance.Keywords
This publication has 35 references indexed in Scilit:
- Immunoregulatory role of transforming growth factor beta (TGF-beta) in development of killer cells: comparison of active and latent TGF-beta 1.The Journal of Experimental Medicine, 1990
- Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential.Proceedings of the National Academy of Sciences of the United States of America, 1990
- The autocrine production of transforming growth factor-beta 1 during lymphocyte activation. A study with a monoclonal antibody-based ELISA.The Journal of Immunology, 1990
- Interaction of growth factors during progression towards steroid independence in T‐47‐D human breast cancer cellsJournal of Cellular Biochemistry, 1990
- Transcripts for transforming growth factors in human breast cancer: clinical correlatesBritish Journal of Cancer, 1990
- A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance.Proceedings of the National Academy of Sciences of the United States of America, 1990
- Differential regulation of expression of three transforming growth factor beta species in human breast cancer cell lines by estradiol.1990
- Approaches to studying the role of growth factors in the progression of breast tumours from the steroid sensitive to insensitive stateJournal of Steroid Biochemistry, 1989
- Growth factors in the regulation of pericellular proteolysis: a review.1989
- Expression of growth factors and oncogenes in normal and tumor-derived human mammary epithelial cells.1988